Skip to main content

Advertisement

Log in

Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile

  • Letter to the Editor
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author contributions

Dr. Amar Mandalia assisted in study concept, design, acquisition of data, drafting of manuscript, and critical revision of the manuscript for important intellectual content. Ms. Angela Ward and Mr. William Tauxe assisted in acquisition of data. Dr. Colleen Kraft lent technical and material support and was involved in critical review of the manuscript for important intellectual content. Dr. Tanvi Dhere was involved in study concept and design, acquisition of data, analysis and interpretation of data, critical revision of the manuscript for important intellectual content, statistical analysis, and overall study supervision.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tanvi Dhere.

Ethics declarations

Grant support

None

Disclosures

The authors have nothing to disclose.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mandalia, A., Ward, A., Tauxe, W. et al. Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile . Int J Colorectal Dis 31, 1059–1060 (2016). https://doi.org/10.1007/s00384-015-2396-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-015-2396-2

Keywords

Navigation